[Preclinical approaches for drugs targeting cognitive deficits of schizophrenia].
Watanabe
Yumi
Y
watanabe.yumi@mf.mt-pharma.co.jp
D000818:Animals; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D003072:Cognition Disorders / Q000188:drug therapy* / Q000378:metabolism; D015195:Drug Design; D005947:Glucose / Q000378:metabolism; D000077408:Modafinil; D051381:Rats; D012565:Schizophrenic Psychology
D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D005947:Glucose; D000077408:Modafinil